You searched for Antibody candidate - Page 10 of 69

News and Trends 29 Oct 2019

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

…target of the drug, and MorphoSys, which generated antibody candidates for the target. Several months after the pair reported positive phase I results last year, Novartis licensed the drug in…

October 29, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

…solid tumors. The drug is a monoclonal antibody, which is a type of protein that can bind to antigens of cancer cells; flagging the cells and could trigger the destruction…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

…results. Its candidate, ABX464, caused a significant reduction of viral reservoirs over a 28-day period. The study included just 11 patients, with 9 completing the study and 8 of those…

December 18, 2017 - 9 minutesmins - By Alex Dale

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…a pipeline of immune-enabling therapies and vaccines for life-threatening bacterial infections associated with biofilms, with a near-term focus on challenging respiratory infections. Clarametyx’s lead candidate is an immune-enabling antibody therapy…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 30 Nov 2023

Could an Alzheimer’s vaccine make treatment more affordable?

…Reuters report, AC Immune is challenging this rhetoric. The Swiss company’s phase 1/2 ABATE trial is testing its Alzheimer’s vaccine candidate ACI-24.060 in patients with Down’s syndrome. The candidate is…

November 30, 2023 - 7 minutesmins - By Roohi Mariam Peter

cancer cell screening drug discovery microplate

News and Trends 7 Oct 2022

GATC AI platform reduces time to find opioid use disorder candidates

…candidates’ safety and efficacy in reducing opioid consumption, withdrawal symptoms and relapse. To discover these specific drug candidates for OUD, GATC obtained addiction drug target biomarkers from Liquid Biosciences, an…

October 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…candidates are engineered T cells designed to express the Tmod receptors, enabling them to differentiate between cancerous and non-cancerous cells. This selective targeting aims to reduce off-target effects and improve…

June 13, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 11 Apr 2024

Seven companies leading the mRNA revolution in biotechnology

…2 results from last week revealed that the seasonal flu vaccine candidate boosted antibody titers at all dose levels and for all encoded seasonal influenza strains across younger and older…

April 11, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Mar 2024

Are these T cell receptor (TCR) therapy companies on your radar?

…and allogeneic candidates as well as antibody-like TCR bispecifics, called T cell Engaging Receptors (TCER). TCERs are biologics that are designed to bind T cells to target and destroy cancer…

March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter

humabs influenza antibody infectious cellclone medimmune

News and Trends 24 Mar 2016

Novel Antibody for Influenza gets FDA Fast-Track Approval

Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track designation. A biologic therapy for Influenza A has been granted…

March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 8 Nov 2017

Phase I Results are in for Swedish Biotech’s Cancer Antibody

…develops antibody-based immunotherapies to fight cancer. Its pipeline includes clinical and pre-clinical drug candidates, including ADC-1013 and ATOR-1015, as well as novel research candidates. The company has announced that its…

November 8, 2017 - 3 minutesmins - By Alex Dale

News and Trends 20 Dec 2019

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

…could be circumvented by delivering simple mRNA blueprints for antibody drugs into the patient, and turning the patient’s own cells into antibody factories. There are challenges to overcome on the…

December 20, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

10 immunotherapy companies making waves in 2023

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

6 biotech companies tackling antibiotic resistance

Could an Alzheimer’s vaccine make treatment more affordable?

GATC AI platform reduces time to find opioid use disorder candidates

Eight companies tackling cancer with allogeneic cell therapy in 2024

Seven companies leading the mRNA revolution in biotechnology

Are these T cell receptor (TCR) therapy companies on your radar?

Novel Antibody for Influenza gets FDA Fast-Track Approval

Phase I Results are in for Swedish Biotech’s Cancer Antibody

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!